NYQ · Price History

Emergent BioSolutions Inc. (EBS) Price History & Returns

$6.23 NYQ: EBS Market Cap $319.43M

How Emergent BioSolutions Inc. (EBS) has performed, year by year and over each trailing period. Price history only — total return to a shareholder would also include dividends.

The share price of $6.23 sits 19% of the way up a 52-week range of $4.36 to $14.06; 55.7% below the 52-week high; a beta of 2.34 means it has historically moved more than the market.

Total return

Price change over each trailing period, not annualised.

PeriodReturn
3 months-6.6%
6 months-37.2%
1 year-2.1%
3 years+2.3%
5 years-87.4%

Year by year

10 of 20 years closed higher than the year before. Closes are the last observation in each calendar year.

YearCloseChange
2026$6.23-49.6%
2025$12.36+29.3%
2024$9.56+298.3%
2023$2.40-79.7%
2022$11.81-72.8%
2021$43.47-51.5%
2020$89.60+66.1%
2019$53.95-9.0%
2018$59.28+27.6%
2017$46.47+41.5%
2016$32.84-17.9%
2015$40.01+46.9%
2014$27.23+18.4%
2013$22.99+43.3%
2012$16.04-4.8%
2011$16.84-28.2%
2010$23.46+72.6%
2009$13.59-48.0%
2008$26.11+416.0%
2007$5.06-54.7%

Monthly closing prices

The last 36 months, newest first. 20 of 36 months closed higher than the month before. Each figure is the last close in that month.

MonthCloseChange
October 2026$6.23-5.6%
September 2026$6.60+8.2%
August 2026$6.10-15.5%
July 2026$7.22-13.8%
June 2026$8.38-8.1%
May 2026$9.12+10.8%
April 2026$8.23-0.8%
March 2026$8.30+1.8%
February 2026$8.15-28.1%
January 2026$11.34-8.3%
December 2025$12.36+10.7%
November 2025$11.17-10.5%
October 2025$12.48+41.5%
September 2025$8.82+6.3%
August 2025$8.30+41.2%
July 2025$5.88-7.8%
June 2025$6.38+0.9%
May 2025$6.32+18.4%
April 2025$5.34+9.9%
March 2025$4.86-35.0%
February 2025$7.48-33.5%
January 2025$11.25+17.7%
December 2024$9.56-5.5%
November 2024$10.12+11.7%
October 2024$9.06+8.5%
September 2024$8.35+0.5%
August 2024$8.31-34.6%
July 2024$12.71+86.4%
June 2024$6.82+19.6%
May 2024$5.70+203.2%
April 2024$1.88-25.7%
March 2024$2.53-21.7%
February 2024$3.23+93.4%
January 2024$1.67-30.4%
December 2023$2.40+12.1%
November 2023$2.14+2.4%

Emergent BioSolutions Inc. (EBS) price history — frequently asked questions

How has Emergent BioSolutions Inc. performed over the last year?

Emergent BioSolutions Inc. (EBS) has fallen 2.1% over the last twelve months, measured on price alone.

What is Emergent BioSolutions Inc.'s five-year return?

Over five years the EBS share price has lost 87.4%, excluding dividends.

What is Emergent BioSolutions Inc.'s 52-week range?

Over the last year Emergent BioSolutions Inc. (EBS) has traded between $4.36 and $14.06.

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksAll stock screens

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.